Cargando…

Human Recombinant Fab Fragment Neutralizes Shiga Toxin Type 2 Cytotoxic Effects in vitro and in vivo

Shiga toxin (Stx) producing Escherichia coli (STEC) is responsible for causing hemolytic uremic syndrome (HUS), a life-threatening thrombotic microangiopathy characterized by thrombocytopenia, hemolytic anemia, and acute renal failure after bacterially induced hemorrhagic diarrhea. Until now, there...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luz, Daniela, Amaral, Maria Marta, Sacerdoti, Flavia, Bernal, Alan Mauro, Quintilio, Wagner, Moro, Ana Maria, Palermo, Marina Sandra, Ibarra, Cristina, Piazza, Roxane Maria Fontes
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6315604/ https://www.ncbi.nlm.nih.gov/pubmed/30513821 http://dx.doi.org/10.3390/toxins10120508

Ejemplares similares

The Deleterious Effects of Shiga Toxin Type 2 Are Neutralized In Vitro by FabF8:Stx2 Recombinant Monoclonal Antibody
por: Luz, Daniela, et al.
Publicado: (2021)

Therapeutic Antibodies Against Shiga Toxins: Trends and Perspectives
por: Henrique, Izabella de Macedo, et al.
Publicado: (2022)

Development and Characterization of Recombinant Antibody Fragments That Recognize and Neutralize In Vitro Stx2 Toxin from Shiga Toxin-Producing Escherichia coli
por: Luz, Daniela, et al.
Publicado: (2015)

Shiga Toxin-Producing Escherichia coli Infections during Pregnancy
por: Sacerdoti, Flavia, et al.
Publicado: (2018)

Ouabain Protects Human Renal Cells against the Cytotoxic Effects of Shiga Toxin Type 2 and Subtilase Cytotoxin
por: Amaral, María M., et al.
Publicado: (2017)

Effects of Shiga Toxin Type 2 on Maternal and Fetal Status in Rats in the Early Stage of Pregnancy
por: Sacerdoti, Flavia, et al.
Publicado: (2014)

Interaction between Shiga Toxin and Monoclonal Antibodies: Binding Characteristics and in Vitro Neutralizing Abilities
por: Rocha, Letícia B., et al.
Publicado: (2012)

Action of Shiga Toxin Type-2 and Subtilase Cytotoxin on Human Microvascular Endothelial Cells
por: Amaral, María M., et al.
Publicado: (2013)

Combined Action of Shiga Toxin Type 2 and Subtilase Cytotoxin in the Pathogenesis of Hemolytic Uremic Syndrome
por: Álvarez, Romina S., et al.
Publicado: (2021)

Humoral immune response to Shiga Toxin 2 (Stx2) among Brazilian urban children with hemolytic uremic syndrome and healthy controls
por: Guirro, Mirian, et al.
Publicado: (2014)

Comparative Characterization of Shiga Toxin Type 2 and Subtilase Cytotoxin Effects on Human Renal Epithelial and Endothelial Cells Grown in Monolayer and Bilayer Conditions
por: Álvarez, Romina S., et al.
Publicado: (2016)

Shiga Toxin Therapeutics: Beyond Neutralization
por: Hall, Gregory, et al.
Publicado: (2017)

Crosstalk between Human Microvascular Endothelial Cells and Tubular Epithelial Cells Modulates Pro-Inflammatory Responses Induced by Shiga Toxin Type 2 and Subtilase Cytotoxin
por: Álvarez, Romina S., et al.
Publicado: (2019)

Detection of Shiga Toxin-Producing Escherichia coli (STEC) in the Endocervix of Asymptomatic Pregnant Women. Can STEC Be a Risk Factor for Adverse Pregnancy Outcomes?
por: Scalise, María Luján, et al.
Publicado: (2022)

Single chain Fab (scFab) fragment
por: Hust, Michael, et al.
Publicado: (2007)

Endocytosis, Cytotoxicity, and Translocation of Shiga Toxin-2 Are Stimulated by Infection of Human Intestinal (HCT-8) Monolayers With an Hypervirulent E. coli O157:H7 Lacking stx2 Gene
por: Garimano, Nicolás, et al.
Publicado: (2019)

HIV-2 neutralization by intact V3-specific Fab fragments
por: Sourial, Samer, et al.
Publicado: (2008)

Soluble CD40 Ligand and Oxidative Response Are Reciprocally Stimulated during Shiga Toxin-Associated Hemolytic Uremic Syndrome
por: Abrey Recalde, Maria J., et al.
Publicado: (2017)

Role of Shiga Toxins in Cytotoxicity and Immunomodulatory Effects of Escherichia coli O157:H7 during Host-Bacterial Interactions in vitro
por: Bruballa, Andrea Cecilia, et al.
Publicado: (2020)

Production of single chain Fab (scFab) fragments in Bacillus megaterium
por: Jordan, Eva, et al.
Publicado: (2007)

Functional Capacity of Shiga-Toxin Promoter Sequences in Eukaryotic Cells
por: Bentancor, Leticia V., et al.
Publicado: (2013)

A Human/Murine Chimeric Fab Antibody Neutralizes Anthrax Lethal Toxin In Vitro
por: Ding, Guipeng, et al.
Publicado: (2013)

Development and Validation of Shiga Toxin-Producing Escherichia coli Immunodiagnostic Assay
por: Silva, Miriam A., et al.
Publicado: (2019)

Human Glomerular Endothelial Cells Treated With Shiga Toxin Type 2 Activate γδ T Lymphocytes
por: Rosso, David Antonio, et al.
Publicado: (2021)

Mouse in Vivo Neutralization of Escherichia coli Shiga Toxin 2 with Monoclonal Antibodies
por: Cheng, Luisa W., et al.
Publicado: (2013)

DutaFabs are engineered therapeutic Fab fragments that can bind two targets simultaneously
por: Beckmann, Roland, et al.
Publicado: (2021)

Production of Antibody Fab Fragments in Escherichia coli
por: Tachibana, Hiroshi, et al.
Publicado: (2011)

Recent Advances in Shiga Toxin-Producing Escherichia coli Research in Latin America
por: Torres, Alfredo G., et al.
Publicado: (2018)

Presence of Shiga toxin 2e-producing Escherichia coli and atypical enteropathogenic E. coli in an asymptomatic child
por: Fernandes, Miriam Rodriguez, et al.
Publicado: (2014)

Roles of Shiga Toxins in Immunopathology
por: Lee, Moo-Seung, et al.
Publicado: (2019)

Protection against Shiga Toxins
por: Kavaliauskiene, Simona, et al.
Publicado: (2017)

Shiga Toxins as Antitumor Tools
por: Robert, Aude, et al.
Publicado: (2021)

Crystal Structure of Human TWEAK in Complex with the Fab Fragment of a Neutralizing Antibody Reveals Insights into Receptor Binding
por: Lammens, Alfred, et al.
Publicado: (2013)

Phylogenetic analysis of Shiga toxin 1 and Shiga toxin 2 genes associated with disease outbreaks
por: Lee, James E, et al.
Publicado: (2007)

Purification and Characterization of Shiga Toxin 2f, an Immunologically Unrelated Subtype of Shiga Toxin 2
por: Skinner, Craig, et al.
Publicado: (2013)

Do the A Subunits Contribute to the Differences in the Toxicity of Shiga Toxin 1 and Shiga Toxin 2?
por: Basu, Debaleena, et al.
Publicado: (2015)

Characterization of Shiga Toxin Subtypes and Virulence Genes in Porcine Shiga Toxin-Producing Escherichia coli
por: Baranzoni, Gian Marco, et al.
Publicado: (2016)

Contribution of cropland to the spread of Shiga toxin phages and the emergence of new Shiga toxin-producing strains
por: Quirós, Pablo, et al.
Publicado: (2017)

The Shiga Toxin Receptor Globotriaosylceramide as Therapeutic Target in Shiga Toxin E. coli Mediated HUS
por: Feitz, Wouter J. C., et al.
Publicado: (2021)

Retrograde transport from the Golgi complex to the ER of both Shiga toxin and the nontoxic Shiga B-fragment is regulated by butyric acid and cAMP
Publicado: (1994)

Cannot write session to /tmp/vufind_sessions/sess_vchostdlg2dcn31985feoauota